rs3207297

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001013703.4(EIF2AK4):​c.4215C>T​(p.Gly1405Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.353 in 1,611,428 control chromosomes in the GnomAD database, including 101,120 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 9232 hom., cov: 31)
Exomes 𝑓: 0.35 ( 91888 hom. )

Consequence

EIF2AK4
NM_001013703.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.0170

Publications

13 publications found
Variant links:
Genes affected
EIF2AK4 (HGNC:19687): (eukaryotic translation initiation factor 2 alpha kinase 4) This gene encodes a member of a family of kinases that phosphorylate the alpha subunit of eukaryotic translation initiation factor-2 (EIF2), resulting in the downregulaton of protein synthesis. The encoded protein responds to amino acid deprivation by binding uncharged transfer RNAs. It may also be activated by glucose deprivation and viral infection. Mutations in this gene have been found in individuals suffering from autosomal recessive pulmonary venoocclusive-disease-2. [provided by RefSeq, Mar 2014]
EIF2AK4 Gene-Disease associations (from GenCC):
  • pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • pulmonary venoocclusive disease 2
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pulmonary venoocclusive disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 15-40020940-C-T is Benign according to our data. Variant chr15-40020940-C-T is described in ClinVar as [Benign]. Clinvar id is 381184.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.017 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.361 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EIF2AK4NM_001013703.4 linkc.4215C>T p.Gly1405Gly synonymous_variant Exon 31 of 39 ENST00000263791.10 NP_001013725.2 Q9P2K8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EIF2AK4ENST00000263791.10 linkc.4215C>T p.Gly1405Gly synonymous_variant Exon 31 of 39 2 NM_001013703.4 ENSP00000263791.5 Q9P2K8-1

Frequencies

GnomAD3 genomes
AF:
0.349
AC:
52926
AN:
151696
Hom.:
9225
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.340
Gnomad AMI
AF:
0.466
Gnomad AMR
AF:
0.327
Gnomad ASJ
AF:
0.366
Gnomad EAS
AF:
0.255
Gnomad SAS
AF:
0.362
Gnomad FIN
AF:
0.331
Gnomad MID
AF:
0.396
Gnomad NFE
AF:
0.364
Gnomad OTH
AF:
0.381
GnomAD2 exomes
AF:
0.341
AC:
84664
AN:
248142
AF XY:
0.346
show subpopulations
Gnomad AFR exome
AF:
0.340
Gnomad AMR exome
AF:
0.283
Gnomad ASJ exome
AF:
0.366
Gnomad EAS exome
AF:
0.244
Gnomad FIN exome
AF:
0.330
Gnomad NFE exome
AF:
0.364
Gnomad OTH exome
AF:
0.364
GnomAD4 exome
AF:
0.353
AC:
515927
AN:
1459612
Hom.:
91888
Cov.:
36
AF XY:
0.355
AC XY:
257867
AN XY:
726128
show subpopulations
African (AFR)
AF:
0.337
AC:
11276
AN:
33414
American (AMR)
AF:
0.290
AC:
12899
AN:
44530
Ashkenazi Jewish (ASJ)
AF:
0.375
AC:
9795
AN:
26086
East Asian (EAS)
AF:
0.285
AC:
11279
AN:
39638
South Asian (SAS)
AF:
0.380
AC:
32628
AN:
85880
European-Finnish (FIN)
AF:
0.331
AC:
17652
AN:
53368
Middle Eastern (MID)
AF:
0.414
AC:
2345
AN:
5666
European-Non Finnish (NFE)
AF:
0.357
AC:
396457
AN:
1110740
Other (OTH)
AF:
0.358
AC:
21596
AN:
60290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
16141
32283
48424
64566
80707
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12528
25056
37584
50112
62640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.349
AC:
52951
AN:
151816
Hom.:
9232
Cov.:
31
AF XY:
0.347
AC XY:
25758
AN XY:
74194
show subpopulations
African (AFR)
AF:
0.340
AC:
14055
AN:
41360
American (AMR)
AF:
0.328
AC:
4997
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.366
AC:
1268
AN:
3466
East Asian (EAS)
AF:
0.254
AC:
1306
AN:
5138
South Asian (SAS)
AF:
0.362
AC:
1744
AN:
4812
European-Finnish (FIN)
AF:
0.331
AC:
3491
AN:
10548
Middle Eastern (MID)
AF:
0.395
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
0.364
AC:
24758
AN:
67930
Other (OTH)
AF:
0.376
AC:
792
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1748
3495
5243
6990
8738
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.361
Hom.:
45293
Bravo
AF:
0.348
Asia WGS
AF:
0.294
AC:
1025
AN:
3478
EpiCase
AF:
0.378
EpiControl
AF:
0.375

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 03, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial pulmonary capillary hemangiomatosis Benign:2
Nov 13, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.28
CADD
Benign
9.8
DANN
Benign
0.69
PhyloP100
-0.017
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=83/17
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3207297; hg19: chr15-40313141; COSMIC: COSV55468419; COSMIC: COSV55468419; API